Neha Patil (Editor)

Medopad

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Type
  
Private

Founded
  
2011

Website
  
www.medopad.com

Headquarters
  
London, United Kingdom

Medopad bambooprcouknewsitewpcontentuploads201504

Industry
  
healthcare, big data, small data, mobile, internet of things, pharma, wearables

Founders
  
Dr Rich Khatib, Rich Khatib, Dan Vahdat

Medopad


Medopad Ltd is a British healthcare technology company based in London, UK. It also has offices in Salt Lake City, USA, and Dubai, UAE. It produces applications that integrate health data from existing hospital databases as well as patient wearables and other mobile devices and securely transmits it for use by doctors.

Contents

Enterprise

Medopad allows hospitals to pool their patient data into a single platform so it can be served to doctors' mobile devices in real-time. Healthcare professionals can securely access lab results, images, clinical notes, and primary care data via iPads and other mobile devices. In November 2013, Medopad became the first enterprise-class mobile health information system to receive CE approval.

Some of the clinical applications that Medopad include editing patient records by voice recognition or typing, scheduling, lab results, image viewing including X-rays and CT scans, electronic support documents, taking and sending photos, video conferencing, primary records, transmitting real-time vital signs, collecting and managing demographic and contact details, Apple HealthKit integration, and arbitrage system to sort and prioritise patients, hospital admission, and access to more third party applications integrated into Medopad through the Clinical App Store.

Carl Reynolds, head of Open Health Care UK told New Scientist that an open system that worked on multiple devices would be preferential to Medopad as it would avoid locking hospitals into a single system. Medopad will cost hospitals between £50 and £90 per month per user to license.

Cancer

In April 2015, Medopad launched a chemotherapy application for monitoring cancer patients designed specifically for the Apple Watch.

Investors

Some of Medopad's institutional investors are Healthbox and Sandbox Industries. Lord Howard Flight and Tony Brown, Non-Executive Director of the NHS both invested individually.

References

Medopad Wikipedia